Moderna CEO Bancel says people may need another booster in fall of 2022

Reuters2022-01-07

Jan 6 (Reuters) - The efficacy of boosters against COVID-19 is likely to decline over the next few months and people may need another shot in the fall of 2022, Moderna Inc Chief Executive Officer Stephane Bancel said at a Goldman Sachs-organized healthcare conference on Thursday.

Bancel said the company is working on a vaccine candidate tailored to the Omicron variant of the coronavirus, but is unlikely to be available in the next two months.

"I still believe we're going to need boosters in the fall of '22 and forward," Bancel said.

His comments on needing a fourth shot come on the back of Israeli Prime Minister Naftali Bennett citing a study

on Tuesday that a fourth dose of COVID-19 vaccine boosts antibodies five-fold a week after the shot is administered.

Moderna, which benefits by repeat inoculations, during its third quarter earnings results said commercial booster market sales could be up to $2 billion in the United States in 2022.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • Mabelicious
    2022-01-07
    Mabelicious
    Will Moderna share price go up? 
  • RO8
    2022-01-07
    RO8
    Of course! 
  • Saintrade
    2022-01-07
    Saintrade
    Big [Miser] 
Leave a comment
3